Results 31 to 40 of about 1,842 (159)

A Patient with Adalimumab-Induced Refractory Paradoxical Palmoplantar Pustulosis Was Successfully Treated by Ixekizumab: A Case Report

Clinical, Cosmetic and Investigational Dermatology, 2023
Xin-Yi Shao, Jian-Xia Xiong, Ai-Jun Chen, Kun Huang, Ping Wang Department of Dermatology, the First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, People’s Republic of ChinaCorrespondence: Ping Wang, Department of Dermatology ...
Shao XY, Xiong JX, Chen AJ, Huang K, Wang P   +4 more
doaj  

Dermatoses neutrofílicas: parte II Neutrophilic dermatoses: part II

Anais Brasileiros de Dermatologia, 2011
Neste artigo são abordadas as dermatoses neutrofílicas, complementando o artigo anterior (parte I). São apresentadas e comentadas as seguintes dermatoses: pustulose subcórnea de Sneddon-Wilkinson, dermatite crural pustulosa e atrófica, pustulose ...
Fernanda Razera, Gislaine Silveira Olm, Renan Rangel Bonamigo   +2 more
doaj   +1 more source

Synovitis, Acne, Pustulosis, Hyperostosis, and Osteitis Syndrome with Purely Osteolytic, Not Osteosclerotic, Lesions Mimicking a Malignant Tumor

Case Reports in Rheumatology, 2020
Synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome is a rare inflammatory disorder with multiple phenotypes. The syndrome has identifiable radiologic characteristics that are the most important when making a diagnosis.
Hideyuki Kinoshita, Takeshi Ishii, Hiroto Kamoda, Yoko Hagiwara, Toshinori Tsukanishi, Sumihisa Orita, Kazuhide Inage, Naoya Hirosawa, Seiji Ohtori, Tsukasa Yonemoto   +9 more
doaj   +1 more source

Palmoplantar pustulosis and IgA nephropathy [PDF]

Journal of General and Family Medicine, 2018
We present a case of IgA nephropathy complicated with palmoplantar pustulosis. The skin lesion improved with tonsillectomy. The purposes of this article were to aid physicians in understanding that (a) IgA nephropathy should be considered in patients with palmoplantar pustulosis and (b) patients with these diseases should be referred to otolaryngology ...
Yoshinosuke Shimamura, Takuto Maeda, Hideki Takizawa   +2 more
openaire   +2 more sources

Possible Efficacy of Vedolizumab, an Anti-α4β7 Integrin Antibody, in Palmoplantar Pustulosis

Case Reports in Dermatology, 2023
Palmoplantar pustulosis (PPP) is a chronic skin inflammatory disease in which blisters and pustules repeatedly develop on palms and soles. PPP is often refractory to topical therapy, oral therapy, phototherapy, and biologics that are usually applied for ...
Hitoshi Terui, Rintaro Moroi, Atsushi Masamune, Setsuya Aiba, Kenshi Yamasaki   +4 more
doaj   +1 more source

Research progress on phosphodiesterase 4 inhibitors in the treatment of palmoplantar pustulosis

Pifu-xingbing zhenliaoxue zazhi
Palmoplantar pustulosis (PPP) is a chronic recurrent inflammatory skin disease. Existing therapeutic methods cannot meet the demand by patients. Phosphodiesterase-4 (PDE-4) is a key enzyme involved in the balance of immunocytes.
YAO Xinyi, Gao Wenli, LI Juan, ZHANG Junling   +3 more
doaj   +1 more source

Transient hypercalcemia in a patient with SAPHO syndrome

Journal of General and Family Medicine, 2022
We here report a case of SAPHO (synovitis‐acne‐pustulosis‐hyperostosis‐osteitis) syndrome with hypercalcemia. The patient was diagnosed with SAPHO syndrome at the age of 54, because he exhibited osteitis and hyperostosis around the sternoclavicular ...
Tadashi Yoshida, Mototsugu Oya
doaj   +1 more source

Exploratory MRI and Clinical Marker Analysis of Pustulotic Arthro‐Osteitis Disease Activity From a Phase 3 Brodalumab Trial

The Journal of Dermatology, EarlyView.
ABSTRACT Pustulotic arthro‐osteitis (PAO) is a clinically important osteoarticular comorbidity affecting approximately 9%–28% of patients with palmoplantar pustulosis (PPP), yet early recognition and standardized activity assessment remain challenging, particularly in routine dermatology practice.
Taiki Nozaki, Manabu Arai, Junko Ochi, Mona Uchida‐Yamada, Masahiro Hashimoto, Mitsuhiro Akiyama, Yuko Kaneko, Yasumasa Kanai, Masahiro Jinzaki   +8 more
wiley   +1 more source

Successful Treatment of a Patient with Pyoderma Gangrenosum, Plaque Psoriasis and Palmoplantar Pustulosis with Adalimumab

Clinical, Cosmetic and Investigational Dermatology, 2022
Yuqi Chu, Taoming Liu, Juan Bai, Hong Fang, Jianjun Qiao Department of Dermatology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, People’s Republic of ChinaCorrespondence: Jianjun Qiao, Department of Dermatology, The ...
Chu Y, Liu T, Bai J, Fang H, Qiao J
doaj  

Safety and pharmacokinetics of anumigilimab for hidradenitis suppurativa or palmoplantar pustulosis: A phase 1b study

Journal of the European Academy of Dermatology and Venereology, EarlyView.
Anumigilimab, a novel anti‐G‐CSF receptor antibody, was investigated in a phase 1b trial involving 39 patients with hidradenitis suppurativa or palmoplantar pustulosis. No serious safety concerns related to anumigilimab were noted, and PK and PD were dose dependent.
Johannes S. Kern, Simon Francis Thomsen, Georgios Kokolakis, Maurizio Podda, Gregor B. E. Jemec, Kurt Gebauer, Claus Zachariae, John Frew, Pablo Fernandez‐Peñas, Falk G. Bechara, Stefan Beissert, Sourabh Malandkar, Karen Scalzo‐Inguanti, Partha Nandy, Selvakumar Sukumar   +14 more
wiley   +1 more source